TGFBR2 and idiopathic pulmonary arterial hypertension: This is consistent with a previous study which revealed no difference in TGFβR2, SMAD2 and SMAD4 in the pulmonary vasculature of iPAH patients, but only a trend of increased p-SMAD2 [35].